Technical Analysis for THOR - Synthorx, Inc.

Grade Last Price % Change Price Change
grade D 15.49 -0.26% -0.04
THOR closed down 0.26 percent on Wednesday, May 22, 2019, on 56 percent of normal volume.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical THOR trend table...

Date Alert Name Type % Chg
Doji - Bullish? Reversal 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Lower Bollinger Band Touch Weakness 0.00%
NR7 Range Contraction -0.26%
Inside Day Range Contraction -0.26%
Down 3 Days in a Row Weakness -0.26%
Lower Bollinger Band Touch Weakness -2.39%
Fell Below 20 DMA Bearish -3.31%
Crossed Above 20 DMA Bullish -8.07%

Older signals for THOR ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a single agent and in combination with an immune checkpoint inhibitor. The company was founded based on important discoveries in Dr. Floyd Romesberg’s lab at The Scripps Research Institute. The company is headquartered in La Jolla, Calif.
Biotechnology Biopharmaceutical Cancer Life Sciences Biology Immune System Tumor Genetics Platform Technology Autoimmune Disorders DNA Molecular Genetics Immune Checkpoint Genetic Code Nucleic Acids
Is THOR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 23.53
52 Week Low 11.0
Average Volume 114,427
200-Day Moving Average 0.0
50-Day Moving Average 18.3654
20-Day Moving Average 16.303
10-Day Moving Average 16.197
Average True Range 1.2274
ADX 27.97
+DI 11.3215
-DI 23.7314
Chandelier Exit (Long, 3 ATRs ) 14.3578
Chandelier Exit (Short, 3 ATRs ) 18.2722
Upper Bollinger Band 17.3622
Lower Bollinger Band 15.2438
Percent B (%b) 0.12
BandWidth 12.993927
MACD Line -0.6481
MACD Signal Line -0.6488
MACD Histogram 0.0007
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 17.23
Resistance 3 (R3) 17.17 16.53 16.94
Resistance 2 (R2) 16.53 16.09 16.56 16.84
Resistance 1 (R1) 16.01 15.81 16.27 16.07 16.75
Pivot Point 15.37 15.37 15.50 15.40 15.37
Support 1 (S1) 14.85 14.93 15.11 14.91 14.23
Support 2 (S2) 14.21 14.65 14.24 14.14
Support 3 (S3) 13.69 14.21 14.04
Support 4 (S4) 13.75